{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:18:25Z","timestamp":1787026705862,"version":"build-2736575974"},"reference-count":87,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2019\/006096"],"award-info":[{"award-number":["CRG\/2019\/006096"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Chronic viral infections represent a leading cause of global morbidity and mortality. Chronic HBV, HCV, and HIV infections result in cytokine perturbations that may hold key implications in understanding the complex disease mechanisms driving virus persistence and\/or resolution. Here, we determined the levels of various plasma cytokines using a commercial Bio-Plex Luminex cytokine array in chronic HBV (\n                    <jats:italic>n<\/jats:italic>\n                    = 30), HCV (\n                    <jats:italic>n<\/jats:italic>\n                    = 15), and HIV (\n                    <jats:italic>n<\/jats:italic>\n                    = 40) infections and correlated with corresponding plasma viral loads (PVLs) and liver parameters. We observed differential perturbations in cytokine profiles among the study groups. The cytokines levels positively correlated with PVL and liver transaminases. The monocyte-derived cytokines viz., MIP-1\u03b2, IL-8, and TNF-\u03b1, and Th2 cytokines like IL-4, IL-5, and IL-13 showed a better correlation with liver enzymes as compared to their corresponding PVLs. Our investigation also identified two cytokines viz., IL-5 and IL-7 that inversely correlated with HBV DNA and HIV PVLs, respectively. Regression analysis adjusted for age showed that every increase of IL-5 by one unit was associated with a reduction in HBV PVL by log\n                    <jats:sub>10<\/jats:sub>\n                    0.4, whereas, every elevation by a unit of IL-7 was associated with decreased HIV PVL by log\n                    <jats:sub>10<\/jats:sub>\n                    2.5. We also found that IL-7 levels correlated positively with absolute CD4+ T cell counts in HIV-infected patients. We concluded that plasma IL-5 and IL-7 may likely have a key role on viral control in HBV and HIV infections, respectively. A noteworthy increase in cytokines appears to bear protective and pathological significance, and indeed is reflective of the host\u2019s versatile immune armory against viral persistence.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2022.1019230","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T01:26:45Z","timestamp":1667438805000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Plasma interleukin-7 correlation with human immunodeficiency virus RNA and CD4+ T cell counts, and interleukin-5 with circulating hepatitis B virus DNA may have implications in viral control"],"prefix":"10.3389","volume":"9","author":[{"given":"Jaisheela","family":"Vimali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yean Kong","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amudhan","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaran","family":"Vishnupriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Ashwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangeline Ann","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pachamuthu","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivadoss","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Rosmawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayakumar","family":"Velu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esaki M.","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","article-title":"Redefining chronic viral infection.","volume":"138","author":"Virgin","year":"2009","journal-title":"Cell."},{"key":"B2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","article-title":"Immunology of hepatitis B virus and hepatitis C virus infection.","volume":"5","author":"Rehermann","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses.","volume":"79","author":"Wieland","year":"2005","journal-title":"J Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/QAD.0000000000000964","article-title":"Distinct cytokine\/chemokine network in semen and blood characterize different stages of HIV infection.","volume":"30","author":"Vanpouille","year":"2016","journal-title":"AIDS."},{"key":"B5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1089\/vim.2020.0176","article-title":"Cytokine, genotype, and viral load profile in the acute and chronic hepatitis B.","volume":"33","author":"Ribeiro","year":"2020","journal-title":"Viral Immunol."},{"key":"B6","year":"2017","journal-title":"Global Hepatitis Report."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.35","article-title":"Hepatitis B virus infection.","volume":"4","author":"Yuen","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B8","year":"2019","journal-title":"Hepatitis C \u2013 Fact Sheet."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/468107","article-title":"Cytokines and HCV-related disorders.","volume":"2012","author":"Fallahi","year":"2012","journal-title":"Clin Dev Immunol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00580","article-title":"Pathophysiology of CD4+ T-cell depletion in HIV-1 and HIV-2 infections.","volume":"8","author":"Vidya Vijayan","year":"2017","journal-title":"Front Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1111\/j.1478-3231.2012.02764.x","article-title":"Pivotal roles of the interleukin-23\/T helper 17 cell axis in hepatitis B.","volume":"32","author":"Huang","year":"2012","journal-title":"Liver Int."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.18892","article-title":"Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection.","volume":"14","author":"Lian","year":"2014","journal-title":"Hepat Mon."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14292","article-title":"Serum TNF-alpha, IL-1beta, and IL-6 levels in chronic HBV-infected patients.","volume":"75","author":"Bekcibasi","year":"2021","journal-title":"Int J Clin Pract."},{"key":"B14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jhep.2019.08.024","article-title":"TNF-alpha\/IFN-gamma profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.","volume":"72","author":"Wang","year":"2020","journal-title":"J Hepatol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11975-7","article-title":"Differential serum cytokine profiles in patients with chronic hepatitis B, C, and hepatocellular carcinoma.","volume":"7","author":"Estevez","year":"2017","journal-title":"Sci Rep."},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1016\/j.inmuno.2014.01.001","article-title":"Evaluation of serum levels of IL-6, TNF-\u03b1, IL-10, IL-2 and IL-4 in patients with chronic hepatitis.","volume":"33","author":"Mourtzikou","year":"2014","journal-title":"Inmunolog\u00eda."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1093\/infdis\/jiw287","article-title":"Cytokines and T-cell homeostasis in HIV infection.","volume":"214","author":"Freeman","year":"2016","journal-title":"J Infect Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1089\/AID.2011.0144","article-title":"Increased levels of circulating cytokines with HIV-related immunosuppression.","volume":"28","author":"Shebl","year":"2012","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/095632020101200301","article-title":"Cytokines and HIV-1: interactions and clinical implications.","volume":"12","author":"Kedzierska","year":"2001","journal-title":"Antivir Chem Chemother."},{"key":"B20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cyto.2017.04.008","article-title":"Cytokine profile in chronic hepatitis C: an observation.","volume":"96","author":"Baskic","year":"2017","journal-title":"Cytokine."},{"key":"B21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00126334-200208150-00004","article-title":"Relationship of HIV viral loads, CD4 counts, and HAART use to health-related quality of life.","volume":"30","author":"Gill","year":"2002","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1086\/378804","article-title":"Viral load and CD4+ T lymphocyte response to highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: an observational study.","volume":"37","author":"Resino","year":"2003","journal-title":"Clin Infect Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1097\/QAD.0000000000001179","article-title":"Polymorphisms in the CD14 and TLR4 genes independently predict CD4+ T-cell recovery in HIV-infected individuals on antiretroviral therapy.","volume":"30","author":"Yong","year":"2016","journal-title":"AIDS."},{"key":"B24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1684\/ecn.2010.0214","article-title":"Serum cytokine levels as putative prognostic markers in the progression of chronic HCV hepatitis to cirrhosis.","volume":"21","author":"Costantini","year":"2010","journal-title":"Eur Cytokine Netw."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0168-0","article-title":"Dengue virus and the host innate immune response.","volume":"7","author":"Uno","year":"2018","journal-title":"Emerg Microbes Infect."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1128\/JVI.02177-12","article-title":"Inhibition of cellular autophagy deranges dengue virion maturation.","volume":"87","author":"Mateo","year":"2013","journal-title":"J Virol."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/srep32243","article-title":"Autophagy-associated dengue vesicles promote viral transmission avoiding antibody neutralization.","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2217\/fmb.12.52","article-title":"Innate barriers to viral infection.","volume":"7","author":"Damania","year":"2012","journal-title":"Future Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.antiviral.2017.02.015","article-title":"AR-12 suppresses dengue virus replication by down-regulation of PI3K\/AKT and GRP78.","volume":"142","author":"Chen","year":"2017","journal-title":"Antiviral Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41577-019-0240-6","article-title":"Efferocytosis in health and disease.","volume":"20","author":"Doran","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.5958\/2319-5886.2016.00007.2","article-title":"Liver function biomakers in malaria and hepatitis B co-infection among patients with febrile illness.","volume":"5","author":"Sharif","year":"2016","journal-title":"Int J Med Res Health."},{"key":"B32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2014.07.018","article-title":"Cell death and cell death responses in liver disease: mechanisms and clinical relevance.","volume":"147","author":"Luedde","year":"2014","journal-title":"Gastroenterology."},{"key":"B33","first-page":"1003","article-title":"Causes and evaluation of mildly elevated liver transaminase levels.","volume":"84","author":"Oh","year":"2011","journal-title":"Am Fam Physician."},{"key":"B34","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/BF01324898","article-title":"The SGOT\/SGPT ratio\u2013an indicator of alcoholic liver disease.","volume":"24","author":"Cohen","year":"1979","journal-title":"Dig Dis Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/QAI.0000000000001082","article-title":"Brief report: HIV-1 infection results in increased frequency of active and inflammatory SlanDCs that produce high level of IL-1beta.","volume":"73","author":"Tufa","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000661","article-title":"IL-1beta processing in host defense: beyond the inflammasomes.","volume":"6","author":"Netea","year":"2010","journal-title":"PLoS Pathog."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.86","article-title":"Caspase-1: is IL-1 just the tip of the ICEberg?","volume":"3","author":"Denes","year":"2012","journal-title":"Cell Death Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1128\/IAI.73.4.1907-1916.2005","article-title":"Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells.","volume":"73","author":"Fink","year":"2005","journal-title":"Infect Immun."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.4049\/jimmunol.1502203","article-title":"Aberrant inflammasome activation characterizes tuberculosis-associated immune reconstitution inflammatory syndrome.","volume":"196","author":"Tan","year":"2016","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1111\/liv.14214","article-title":"HBV-Pol is crucial for HBV-mediated inhibition of inflammasome activation and IL-1beta production.","volume":"39","author":"Lei","year":"2019","journal-title":"Liver Int."},{"key":"B41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/JLB.4A1018-381R","article-title":"HIV infection modulates IL-1beta response to LPS stimulation through a TLR4-NLRP3 pathway in human liver macrophages.","volume":"105","author":"Zhang","year":"2019","journal-title":"J Leukoc Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00262-012-1208-6","article-title":"Interleukin-1beta enhances the production of soluble MICA in human hepatocellular carcinoma.","volume":"61","author":"Kohga","year":"2012","journal-title":"Cancer Immunol Immunother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.4049\/jimmunol.1002000","article-title":"CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7.","volume":"186","author":"Catalfamo","year":"2011","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.cell.2011.01.011","article-title":"IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology.","volume":"144","author":"Pellegrini","year":"2011","journal-title":"Cell."},{"key":"B45","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/emm.2006.82","article-title":"Association of common promoter polymorphisms of MCP1 with hepatitis B virus clearance.","volume":"38","author":"Park","year":"2006","journal-title":"Exp Mol Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7754\/Clin.Lab.2017.171218","article-title":"Serum monocyte chemoattractant protein-1 predicts liver inflammation of patients with chronic hepatitis B.","volume":"64","author":"Fan","year":"2018","journal-title":"Clin Lab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/vim.2010.0065","article-title":"Sustained high levels of serum interferon-gamma during HIV-1 infection: a specific trend different from other cytokines.","volume":"23","author":"Watanabe","year":"2010","journal-title":"Viral Immunol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00498","article-title":"The significance of interferon-gamma in HIV-1 pathogenesis, therapy, and prophylaxis.","volume":"4","author":"Roff","year":"2014","journal-title":"Front Immunol."},{"key":"B49","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1182\/blood.V88.11.4239.bloodjournal88114239","article-title":"Interleukin-7 is a critical growth factor in early human T-cell development.","volume":"88","author":"Plum","year":"1996","journal-title":"Blood."},{"key":"B50","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/83381","article-title":"Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis.","volume":"7","author":"Napolitano","year":"2001","journal-title":"Nat Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1310\/6V29-4UU5-Y3FP-JERT","article-title":"Circulating levels of interleukin-7 in antiretroviral-naive and highly active antiretroviral therapy-treated HIV-infected patients.","volume":"2","author":"Mastroianni","year":"2001","journal-title":"HIV Clin Trials."},{"key":"B52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.cyto.2017.12.014","article-title":"Interleukin-7 augments CD8(+) T cells function and promotes viral clearance in chronic hepatitis C virus infection.","volume":"102","author":"Hou","year":"2018","journal-title":"Cytokine."},{"key":"B53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1089\/vim.2018.0010","article-title":"Interleukin-7 regulates T follicular helper cell function in patients with chronic hepatitis C.","volume":"31","author":"Zhang","year":"2018","journal-title":"Viral Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.cell.2011.01.038","article-title":"IL-7 knocks the socs off chronic viral infection.","volume":"144","author":"Parish","year":"2011","journal-title":"Cell."},{"key":"B55","doi-asserted-by":"publisher","first-page":"914","DOI":"10.4049\/jimmunol.176.2.914","article-title":"IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy.","volume":"176","author":"Beq","year":"2006","journal-title":"J Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/s1471-490602028-2","article-title":"Interleukin-7: master regulator of peripheral T-cell homeostasis?","volume":"22","author":"Fry","year":"2001","journal-title":"Trends Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/00002030-200402200-00025","article-title":"HIV infection: pre-highly active antiretroviral therapy IL-7 plasma levels correlate with long-term CD4 cell count increase after treatment.","volume":"18","author":"Beq","year":"2004","journal-title":"AIDS."},{"key":"B58","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1046\/j.1468-1293.2003.00165.x","article-title":"Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir\/ritonavir-based therapy.","volume":"4","author":"Boulassel","year":"2003","journal-title":"HIV Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1651-2227.2005.tb01886.x","article-title":"Homeostatic role of IL-7 in HIV-1 infected children on HAART: association with immunological and virological parameters.","volume":"94","author":"Resino","year":"2005","journal-title":"Acta Paediatr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/QAD.0000000000001760","article-title":"IL-7 treatment supports CD8+ mucosa-associated invariant T-cell restoration in HIV-1-infected patients on antiretroviral therapy.","volume":"32","author":"Sortino","year":"2018","journal-title":"AIDS."},{"key":"B61","doi-asserted-by":"publisher","first-page":"10319","DOI":"10.1128\/JVI.75.21.10319-10325.2001","article-title":"Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals.","volume":"75","author":"Llano","year":"2001","journal-title":"J Virol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"468","DOI":"10.15386\/cjmed-531","article-title":"The importance of the granulocyte-colony stimulating factor in oncology.","volume":"88","author":"Cetean","year":"2015","journal-title":"Clujul Med."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.885829","article-title":"Granulocyte colony-stimulating factor accelerates the recovery of hepatitis B virus-related acute-on-chronic liver failure by promoting M2-like transition of monocytes.","volume":"13","author":"Tong","year":"2022","journal-title":"Front Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12072-017-9814-1","article-title":"Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage.","volume":"11","author":"Saha","year":"2017","journal-title":"Hepatol Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1089\/jir.2014.0149","article-title":"Dual role of GM-CSF as a pro-inflammatory and a regulatory cytokine: implications for immune therapy.","volume":"35","author":"Bhattacharya","year":"2015","journal-title":"J Interferon Cytokine Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1080\/21645515.2016.1221551","article-title":"Novel GM-CSF-based vaccines: one small step in GM-CSF gene optimization, one giant leap for human vaccines.","volume":"12","author":"Yu","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4130-0","article-title":"Potential circulating biomarkers of circulating chemokines CCL5, MIP-1beta and HA as for early detection of cirrhosis related to chronic HBV (hepatitis B virus) infection.","volume":"19","author":"Hu","year":"2019","journal-title":"BMC Infect Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1006\/clin.1995.1034","article-title":"Interleukin-8 and granulocyte-macrophage colony-stimulating factor secretion in hepatocellular carcinoma and viral chronic active hepatitis.","volume":"74","author":"al-Wabel","year":"1995","journal-title":"Clin Immunol Immunopathol."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105073","article-title":"Remodeling of immunological biomarkers in patients with chronic hepatitis C treated with direct-acting antiviral therapy.","volume":"190","author":"Ribeiro","year":"2021","journal-title":"Antiviral Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1365-2893.1997.tb00158.x","article-title":"Interleukin-12: potential clinical applications in the treatment of chronic viral hepatitis.","volume":"4","author":"Gately","year":"1997","journal-title":"J Viral Hepat."},{"key":"B71","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2893.2007.00908.x","article-title":"Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.","volume":"15","author":"Gigi","year":"2008","journal-title":"J Viral Hepat."},{"key":"B72","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1034\/j.1600-0463.2000.d01-93.x","article-title":"Effect of IL-12 on T-cell immune responses in patients with chronic HCV infection.","volume":"108","author":"Fan","year":"2000","journal-title":"APMIS."},{"key":"B73","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.cellimm.2011.10.016","article-title":"Serum levels of interleukin-12 in various clinical states with hepatitis B virus infection.","volume":"272","author":"He","year":"2012","journal-title":"Cell Immunol."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.816515","article-title":"Targeting CCR5 as a component of an HIV-1 therapeutic strategy.","volume":"12","author":"Mohamed","year":"2021","journal-title":"Front Immunol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075500","article-title":"IL-1beta enriched monocytes mount massive IL-6 responses to common inflammatory triggers among chronically HIV-1 infected adults on stable anti-retroviral therapy at risk for cardiovascular disease.","volume":"8","author":"Jalbert","year":"2013","journal-title":"PLoS One."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1089\/AID.2012.0348","article-title":"Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problems.","volume":"29","author":"Fuster","year":"2013","journal-title":"AIDS Res Hum Retroviruses."},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease.","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00436-005-0081-z","article-title":"Serum cytokine levels in human ascariasis and toxocariasis.","volume":"98","author":"Malla","year":"2006","journal-title":"Parasitol Res."},{"key":"B79","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S1081-120663281-4","article-title":"Biology of IL-5 in health and disease.","volume":"82","author":"Lalani","year":"1999","journal-title":"Ann Allergy Asthma Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1099\/0022-1317-82-6-1349","article-title":"The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus).","author":"Strestik","year":"2001","journal-title":"J Gen Virol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1099\/0022-1317-83-5-1183","article-title":"Co-expression of interleukin-5 influences replication of simian\/human immunodeficiency viruses in vivo.","author":"Kozyrev","year":"2002","journal-title":"J Gen Virol."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235865","article-title":"Outcome markers of ART-treated HIV+ patients with early stage Kaposi\u2019s sarcoma.","volume":"15","author":"Ngalamika","year":"2020","journal-title":"PLoS One."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/757246","article-title":"Circulating cytokines and histological liver damage in chronic hepatitis B infection.","volume":"2013","author":"Poovorawan","year":"2013","journal-title":"Hepat Res Treat."},{"key":"B84","first-page":"93","article-title":"Evaluation of serum IFN- and IL-5 levels in response to entecavir therapy in patients with chronic hepatitis B virus infection.","volume":"25","author":"Badary","year":"2018","journal-title":"Egypt J Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/COH.0000000000000348","article-title":"The evolving role of CD4 cell counts in HIV care.","volume":"12","author":"Ford","year":"2017","journal-title":"Curr Opin HIV AIDS."},{"key":"B86","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1097\/00002030-199715000-00003","article-title":"AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.","volume":"11","author":"de Wolf","year":"1997","journal-title":"AIDS."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1019230\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T01:26:53Z","timestamp":1667438813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1019230\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,3]]},"references-count":87,"alternative-id":["10.3389\/fmed.2022.1019230"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1019230","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,3]]},"article-number":"1019230"}}